MYERS MICHAEL enters QUOIN PHARMACEUTICALS, LTD. with 561.48M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/3/2023ACC: 0001104659-23-000145
DirectorOfficer· Chief Executive Officer
Since Feb 2026
561.48M
Baseline shares
100% direct
561.48M
Direct ownership
1 position
428.57M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned561.48M
Total
561.48M direct561.48M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 561.48M | Direct |
| Total | 561.48M | 561.48M direct |
Derivative Holdings1
Share Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
428.57M
Shares owned
N/A
Exercise price
0.0035
Expiration
—
Exercise window
—
Total
Underlying
428.57M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares | 0.0035 | — | — | 428.57M | N/A |
| Total | 428.57M | 0.00 | ||||